Gainers
Miromatrix Medical Inc. (MIRO) witnessed a 232% surge in pre-market trading to reach $3.36. This increase can be attributed to the news of United Therapeutics Corporation’s (UTHR) acquisition of Miromatrix Medical for $3.25 per share in cash, totaling approximately $91 million.
Conduit Pharmaceuticals Inc. (CDT) experienced a 70.6% surge in pre-market trading, reaching $1.74. This rise comes after a 12% drop in stock price on Friday.
reAlpha Tech Corp. (AIRE) witnessed a 22% gain in pre-market trading, reaching $28.26. The stock price had dipped around 54% on Friday.
My Size, Inc. (MYSZ) saw a 21.4% climb in pre-market trading, reaching $0.8498.
Coherus BioSciences, Inc. (CHRS) observed a 16.2% rise in pre-market trading, reaching $3.07. This increase is due to the FDA’s approval of LOQTORZI in all lines of treatment for recurrent or metastatic nasopharyngeal carcinoma, announced by Coherus and Junshi Biosciences.
Motus GI Holdings, Inc. (MOTS) gained 12.8% in pre-market trading, reaching $0.4625. The recent FDA clearance for commercializing Pure-Vu EVS Gastro and Gen 4 Colon contributed to this rise in stock price.
Biophytis S.A. (BPTS) shares rose 12.7% in pre-market trading to reach $0.80. The company signed a partnership agreement with Innovation Solutions Pharma to accelerate market access for Sarconeos (BIO101) in Brazil.
Eyenovia, Inc. (EYEN) witnessed a 12.1% increase in pre-market trading, reaching $1.21. The stock had experienced a more than 3% fall on Friday.
Intuitive Machines, Inc. (LUNR) rose 11.6% in pre-market trading, reaching $2.98. The company announced that the IM-1 lunar mission liftoff, in coordination with SpaceX, is now targeted for a multi-day launch window, starting January 12, 2024.
BeiGene, Ltd. (BGNE) gained 10.3% in pre-market trading, reaching $188.00. Recently, BRUKINSA received a positive recommendation from NICE in the UK for adult patients with chronic lymphocytic leukemia.
Losers
Biophytis (BKYI) dipped 24.2% in pre-market trading, reaching $0.1668. On Friday, the stock had jumped over 28%. BIO-Key International recently reported a narrower quarterly loss.
The Alkaline Water Company Inc. (WTER) saw a 17.7% fall in pre-market trading, reaching $0.2250. On Friday, the stock had gained 8%.
Medicenna Therapeutics Corp. (MDNA) experienced a 13.6% decline in pre-market trading, reaching $0.1651. The company will be delisted from the Nasdaq and is reducing its management team, resulting in the stock falling 21% on Friday.
Nuvve Holding Corp. (NVVE) witnessed a 12.6% fall in pre-market trading, reaching $0.1879. Recently, Nuvve announced the pricing of a $2.066-million registered direct offering, priced at-the-market.
Vaxart, Inc. (VXRT) shares fell 10.7% in pre-market trading, reaching $0.60. The company is expected to report financial results for the third quarter after the market closes on November 2, 2023.
Fangdd Network Group Ltd. (DUO) experienced a 10.6% fall in pre-market trading, reaching $0.93. On Friday, the stock had surged around 36%.
Crown ElectroKinetics Corp. (CRKN) fell 9.2% in pre-market trading, reaching $0.2261.
Harpoon Therapeutics, Inc. (HARP) fell 9.1% in pre-market trading, reaching $4. The company recently announced a private placement of up to $150 million.
MingZhu Logistics Holdings Limited (YGMZ) shares fell 7.5% in pre-market trading, reaching $0.55.
SeaStar Medical Holding Corporation (ICU) fell 6.1% in pre-market trading, reaching $0.9580. On Friday, the stock had surged over 28%.
Now Read This: Jim Cramer Wants You To ‘Stay Away’ From This Energy Corporation: ‘I’ve Got So Many Other Good Oil Companies’
